Login / Signup

Targeted Nanotherapeutics Using LACTB Gene Therapy Against Melanoma.

Jinlu LiuLing YangXin YuanMeimei XiongJiao ZhuWenbi WuMin RenJianlin LongXuewen XuMaling Gou
Published in: International journal of nanomedicine (2021)
The downregulated LACTB might be a potential target for melanoma therapy. The iDPP/LACTB nanocomplexes could inhibit the growth of the mouse melanoma without obvious side effects, which provide a new option for melanoma gene therapy research.
Keyphrases
  • gene therapy
  • skin cancer
  • basal cell carcinoma
  • risk assessment
  • human health
  • replacement therapy